Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z)
Other Scholarly Work
Lauko, A, Kotecha, R, Barnett, A et al. (2022). Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z)
. 12(1), 10.1038/s41598-022-05489-0
Lauko, A, Kotecha, R, Barnett, A et al. (2022). Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z)
. 12(1), 10.1038/s41598-022-05489-0
The original version of this Article contained an error in the Funding section. “This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.” now reads: “This work was partially funded by the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship F30CA250254 (AL).” The original Article has been corrected.